                         SEQUENCE LISTING

<110>  University of Washington
 
<120>  DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF 
       VIRAL RNA STRUCTURES

<130>  UWOTL-1-74223

<150>  US 63/031,097
<151>  2020-05-28

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-proline

<400>  1

Pro Arg Val Arg Thr Arg Gly Lys Arg Arg Ile Arg Pro Xaa 
1               5                   10                  


<210>  2
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-proline

<400>  2

Pro Arg Val Arg Thr Arg Lys Gly Arg Arg Ile Arg Ile Xaa 
1               5                   10                  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  diaminobutyric acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  norarginine (2-amino-4-guanidinobutanonic acid)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-proline

<400>  3

Pro Xaa Val Arg Thr Arg Lys Gly Arg Arg Ile Xaa Ile Xaa 
1               5                   10                  


<210>  4
<211>  39
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  4
gacugauguu gacuguugaa ucucauggca acaccaguc                              39


<210>  5
<211>  29
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  5
ggcagaucug agccugggag cucucugcc                                         29


<210>  6
<211>  42
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  6
ggcaaaugag gcgcugcaug uggcagucug ccucucuuug cc                          42


<210>  7
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  7
ctatagtgag tcgtatta                                                     18


